Literature DB >> 20228196

Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.

Scott E Hensley1, Damien Zanker, Brian P Dolan, Alexandre David, Heather D Hickman, Alan C Embry, Cara N Skon, Kristie M Grebe, Thomas A Griffin, Weisan Chen, Jack R Bennink, Jonathan W Yewdell.   

Abstract

Proteasomes are multisubunit proteases that initiate degradation of many Ags presented by MHC class I molecules. Vertebrates express alternate forms of each of the three catalytic proteasome subunits: standard subunits, and immunosubunits, which are constitutively expressed by APCs and are induced in other cell types by exposure to cytokines. The assembly of mixed proteasomes containing standard subunits and immunosubunits is regulated in a tissue specific manner. In this study, we report that the presence of mixed proteasomes in immune cells in LMP2(-/-) mice compromises multiple components that contribute to the generation of antiviral Ab responses, including splenic B cell numbers, survival and function of adoptively transferred B cells, Th cell function, and dendritic cell secretion of IL-6, TNF-alpha, IL-1beta, and type I IFNs. These defects did not result from compromised overall protein degradation, rather they were associated with altered NF-kappaB activity. These findings demonstrate an important role for immunoproteasomes in immune cell function beyond their contribution to Ag processing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228196      PMCID: PMC2941094          DOI: 10.4049/jimmunol.0903003

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Different proteasome subtypes in a single tissue exhibit different enzymatic properties.

Authors:  B Dahlmann; T Ruppert; L Kuehn; S Merforth; P M Kloetzel
Journal:  J Mol Biol       Date:  2000-11-10       Impact factor: 5.469

2.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Authors:  A Le Bon; G Schiavoni; G D'Agostino; I Gresser; F Belardelli; D F Tough
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

4.  Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing.

Authors:  T Hoppe; K Matuschewski; M Rape; S Schlenker; H D Ulrich; S Jentsch
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

5.  LMP2 expression and proteasome activity in NOD mice.

Authors:  H A Runnels; W A Watkins; J J Monaco
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

6.  Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency.

Authors:  Zheqing P Cai; Zhenyun Shen; Luc Van Kaer; Lewis C Becker
Journal:  FASEB J       Date:  2008-08-26       Impact factor: 5.191

7.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology.

Authors:  C Asselin-Paturel; A Boonstra; M Dalod; I Durand; N Yessaad; C Dezutter-Dambuyant; A Vicari; A O'Garra; C Biron; F Brière; G Trinchieri
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

8.  Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus.

Authors:  Z Sha; R W Compans
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  NOD mice are defective in proteasome production and activation of NF-kappaB.

Authors:  T Hayashi; D Faustman
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

10.  Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

Authors:  W Chen; C C Norbury; Y Cho; J W Yewdell; J R Bennink
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  51 in total

Review 1.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.

Authors:  Eun Ryoung Jang; Na-Ra Lee; Songhee Han; Ying Wu; Lalit Kumar Sharma; Kimberly Cornish Carmony; James Marks; Do-Min Lee; Jung-Ok Ban; Marie Wehenkel; Jin Tae Hong; Kyung Bo Kim; Wooin Lee
Journal:  Mol Biosyst       Date:  2012-06-22

3.  Editorial: Proteostenosis: cancer's Achilles heel?

Authors:  Jonathan W Yewdell; Alexandre David
Journal:  J Leukoc Biol       Date:  2012-11       Impact factor: 4.962

Review 4.  Emerging roles of immunoproteasomes beyond MHC class I antigen processing.

Authors:  Frédéric Ebstein; Peter-Michael Kloetzel; Elke Krüger; Ulrike Seifert
Journal:  Cell Mol Life Sci       Date:  2012-03-02       Impact factor: 9.261

5.  Molecular characterization and expressional affirmation of the beta proteasome subunit cluster in rock bream immune defense.

Authors:  Saranya Revathy Kasthuri; Navaneethaiyer Umasuthan; Ilson Whang; Bong-Soo Lim; Hyung-Bok Jung; Myung-Joo Oh; Sung-Ju Jung; Sang-Yeob Yeo; Sung Yeon Kim; Jehee Lee
Journal:  Mol Biol Rep       Date:  2014-05-28       Impact factor: 2.316

6.  Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigens.

Authors:  Srdjan M Dragovic; Timothy Hill; Gregory J Christianson; Sungjune Kim; Tim Elliott; Diane Scott; Derry C Roopenian; Luc Van Kaer; Sebastian Joyce
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

Review 7.  Emerging role of immunoproteasomes in pathophysiology.

Authors:  Gagandeep Kaur; Sanjay Batra
Journal:  Immunol Cell Biol       Date:  2016-06-14       Impact factor: 5.126

8.  Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.

Authors:  Henry W B Johnson; Janet L Anderl; Erin K Bradley; John Bui; Jeffrey Jones; Shirin Arastu-Kapur; Lisa M Kelly; Eric Lowe; David C Moebius; Tony Muchamuel; Christopher Kirk; Zhengping Wang; Dustin McMinn
Journal:  ACS Med Chem Lett       Date:  2017-03-09       Impact factor: 4.345

9.  Mycobacterium tuberculosis-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways.

Authors:  Jessica Jarvela; Michelle Moyer; Patrick Leahy; Tracey Bonfield; David Fletcher; Wambura N Mkono; Htin Aung; David H Canaday; Jean-Eudes Dazard; Richard F Silver
Journal:  J Immunol       Date:  2019-09-20       Impact factor: 5.422

10.  Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.

Authors:  Mary K McCarthy; Danielle H Malitz; Caitlyn T Molloy; Megan C Procario; Kaitlyn E Greiner; Luna Zhang; Ping Wang; Sharlene M Day; Saul R Powell; Jason B Weinberg
Journal:  Virology       Date:  2016-08-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.